López-González GJD, Aguilar JMP, Clavero GE, Ruiz FMC

Language: Spanish
References: 7
Page: 282-284
PDF size: 315.52 Kb.

ABSTRACT

Cytomegalovirus (CMV) is the most important pathogen causing opportunistic infections in renal allograft recipients. The development of CMV disease is associated with increased morbidity, a higher incidence of other opportunistic infections, loss of allografts, and death. Therefore, an effective strategy is required to prevent CMV disease after kidney transplantation. We present the case of a patient who suffers from a severe gastrointestinal condition due to the pathogen itself with subsequent adequate clinical evolution.

REFERENCES

1. Kotton CN, Fishman JA. Viral infection in the renaltransplant recipient. J Am Soc Nephrol. 2005;16(6):1758-74. doi: 10.1681/ASN.2004121113.

2. De Keyzer K, Van Laecke S, Peeters P, Vanholder R.Human cytomegalovirus and kidney transplantation:a clinician’s update. Am J Kidney Dis. 2011;58(1):118-26. doi: 10.1053/j.ajkd.2011.04.010.

3. Helanterä I, Egli A, Koskinen P, Lautenschlager I,Hirsch HH. Viral impact on long-term kidney graftfunction. Infect Dis Clin North Am. 2010;24(2):339-71. doi: 10.1016/j.idc.2010.02.003.

4. Hanley PJ, Bollard CM. Controlling cytomegalovirus:helping the immune system take the lead. Viruses.2014;6(6):2242-58. doi: 10.3390/v6062242.

5. Kotton CN, Kumar D, Caliendo AM, Asberg A, ChouS, Danziger-Isakov L, Humar A; TransplantationSociety International CMV Consensus Group.Updated International Consensus Guidelines on theManagement of Cytomegalovirus in Solid-OrganTransplantation. Transplantation. 2013;96(4):333-60.doi: 10.1097/TP.0b013e31829df29d.

6. Torre-Cisneros J, Aguado JM, Caston JJ, AlmenarL, Alonso A, Cantisán S, et al.; Spanish Society ofTransplantation (SET); Group for Study of Infectionin Transplantation of the Spanish Society of InfectiousDiseases and Clinical Microbiology (GESITRASEIMC);Spanish Network for Research in InfectiousDiseases (REIPI). Management of cytomegalovirusinfection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.Transplant Rev (Orlando). 2016;30(3):119-43. doi:10.1016/j.trre.2016.04.001.

7. Kotton CN, Kumar D, Caliendo AM, Huprikar S,Chou S, Danziger-Isakov L, et al.; The TransplantationSociety International CMV Consensus Group. TheThird International Consensus Guidelines on theManagement of Cytomegalovirus in Solid-organTransplantation. Transplantation. 2018;102(6):900-31.doi: 10.1097/TP.0000000000002191.